HOUSTON, Feb. 06, 2017 -- Sanchez Energy Corporation (NYSE: SN) (“Sanchez Energy” or the “Company”), announced today the closing of an underwritten public offering of an aggregate of 11,500,000 shares of the Company's common stock at a price to the public of $12.50 per share. The shares sold to the underwriters included 1,500,000 shares, pursuant to a 30-day option that was exercised by the underwriters in full. The Company received gross proceeds (before underwriting discounts and commissions and estimated expenses) of approximately $143.8 million. The Company intends to use the net proceeds from this offering for general corporate purposes, including working capital.
J.P. Morgan Securities LLC, Citigroup and Johnson Rice & Company L.L.C. are acting as joint book-running managers for the offering. The offering will be made only by means of a prospectus supplement and the accompanying base prospectus. An investor may obtain free copies of both the prospectus supplement and the accompanying base prospectus by visiting EDGAR on the SEC's website at www.sec.gov. Alternatively, Sanchez or the book-running managers will arrange to send you the prospectus supplement and the accompanying base prospectus if you request them by contacting J.P. Morgan Securities LLC, via Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by calling toll-free at (866) 803-9204, Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by calling toll-free at (800)-831-9146, or Johnson Rice & Company L.L.C., attn: Syndicate Department, 639 Loyola Avenue, Suite 2275, New Orleans, Louisiana 70112, or by telephone at (800) 443-5924.
This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful. The offering is being made pursuant to an effective registration statement on Form S-3 previously filed by the Company with the Securities and Exchange Commission
ABOUT SANCHEZ ENERGY CORPORATION
Sanchez Energy Corporation (NYSE:SN) is an independent exploration and production company focused on the acquisition and development of U.S. onshore unconventional oil and natural gas resources, with a current focus on the Eagle Ford Shale in South Texas where we have assembled over 275,000 net acres. For more information about Sanchez Energy Corporation, please visit our website: www.sanchezenergycorp.com.
COMPANY CONTACT: Howard J. Thill EVP & Chief Financial Officer (713) 783-8000 Kevin Smith VP Investor Relations (281) 925-4828 Cham King Investor Relations & Capital Markets (713) 756-2797 General Inquiries: (713) 783-8000 www.sanchezenergycorp.com


Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



